CClinicalTrials.gg
Enrolling by invitationNCT07491627ENIPT'sUpdated Apr 22, 2026

Effect of Nicotine Gingival Fibroblast Intoxication on the Response of Periodontal Treatment

An interventional study of periodontal non-surgical treatment in Periodontitis, Smoking Cessation and Tobacco Dependence, sponsored by University of Liege. Enrolling by invitation at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-22.

Sponsored by University of Liege · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jan 2025, registered Apr 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

Impact of nicotine gingival intoxication on the clinical outcomes after periodontitis non surgical treatment

Read the detailed description

In patients suffured of periodontitis, to evaluate the effect of nicotine gingival tissue intoxication and others smoking indicators on the severity of periodontitis and outcomes after nonsurgical periodontal treatment."

02

Conditions studied

  • Periodontitis
  • Smoking Cessation
  • Tobacco Dependence

Keywords

  • periodontitis
  • nicotine gingival intoxication
  • periodontal outcomes
  • periodontitis non surgical treatment
03

In context

Periodontitis

1,637 studies on the registry are indexed under Periodontitis; 327 are open to participants now.

This study's planned enrollment of 56 is above the median of 45 across 1,191 interventional studies indexed under Periodontitis.

Browse Periodontitis studies →

Lead sponsor

University of Liege is the lead sponsor of 242 studies on the registry; 46 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria: patient suffured of periodontitis, smoker and non-smoker

  • patient suffured of periodontitis
  • smoker and non-smoker
  • presence of a minimum of 6 teeth at each arch
  • minimum of 6 teeth with pocket depth of 5 mm
  • signed informed consent

Exclusion Criteria:

  • diabetes,
  • connective tissue disease
  • pregnancy
  • radiotherapy
  • chemotherapy
  • psychological disease
  • previous periodontal therapy
  • antibiotics intake
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
56 participants (estimated)

Study arms

  • Active comparator
    conventionnal smoker group

    patient who smokes conventionnal cigarette

    Procedure: periodontal non-surgical treatment

  • Placebo comparator
    Non smoker group

    patient who don't smoke cigarette

    Procedure: periodontal non-surgical treatment

Interventions

  • Procedureperiodontal non-surgical treatment

    The procedure will consist of non-surgical periodontal treatment (NSPT), consisting of the removal of supra- and subgingival plaque using ultrasonic instruments. Prior to the NSPT, all unstimulated saliva will be collected using Eppendorf. During local anesthesia for the NSPT, a gingival tissue biopsy will be performed using a 2mm wide and 4mm deep punch in the maxillary retromolar area behind the last tooth in the arch.

06

What researchers measure

Primary outcomes

  1. nicotine/cotinine in gum (ng/ml)

    concentration cotinine and nicotine (ng/ml)

    Time frame: the day of the periodontal non surgical treatment

Secondary outcomes

  1. PD (mm)

    periodontal pocket depth (mm) Secondary outcomes: percentage of sites with PD ≥ 6 mm, furcation involvement, mobility assessment, bleeding on probing score (BoP), plaque score (PI).

    Time frame: baseline, the day of periodontal non- surgical treatment(PNST) , 3,6 and 12 months after PNSTs after

  2. % PD ≥ 6 mm (%)

    percentage of sites with PD ≥ 6 mm

    Time frame: baseline, the day of periodontal non- surgical treatment(PNST) , 3,6 and 12 months after PNSTs after

  3. FTND score ( 0 to 9)

    Fagerström test for nictnie dependance ( scale from 0 to 9) 0-2: Very low dependence 3-4: Low dependence 5: Medium dependence 6-7: High dependence 8-10: Very high dependence

    Time frame: the day of periodontal non-surgical treatment

  4. PY (number/year)

    number of packet of cigarettes smoked per year

    Time frame: the day of periodontal non-surgical treatment

  5. NCC (0 to 100)

    number of cigartes consummed per day * PK: number of packet of cigarettes smoked per year * FTND: Fagerström test for nictnie dependance

    Time frame: the day of periodontal non-surgical treatment

  6. Furc (I,II or III)

    furcation involvement

    Time frame: baseline, the day of periodontal non- surgical treatment(PNST) , 3,6 and 12 months after PNSTs after

  7. periodontal ouctomes

    tooth mobility ( 1,2 or 3)

    Time frame: baseline, the day of periodontal non- surgical treatment(PNST) , 3,6 and 12 months after PNSTs after

  8. BOP (%)

    bleeding on probing

    Time frame: baseline, the day of periodontal non- surgical treatment(PNST) , 3,6 and 12 months after PNSTs after

  9. PI (%)

    plaque score

    Time frame: baseline, the day of periodontal non- surgical treatment(PNST) , 3,6 and 12 months after PNSTs after

07

Study locations

1 site
  • Departement of periodontology, buccal surgery and implantology- Uliège, Belgium
    Liège, Liege 4000, Belgium
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07491627
Lead sponsor
University of Liege
Responsible party
Leila Salhi (PhD dental sciences, University of Liege) — Principal investigator
First posted
Mar 24, 2026
Start date
Jan 6, 2025
Primary completion
Jun 2029 (estimated)
Completion
Jun 2029 (estimated)
Last update
Apr 22, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion